Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN25146122
ISRCTN25146122
Completed
N/A

Testing the effectiveness, acceptability and feasibility of DIALOG+ in severe mental illness in Uganda: a randomised controlled trial

Queen Mary University of London0 sites182 target enrollmentNovember 20, 2018
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsMental, neurological and substance misuse disorders, which includes severe mental illness (psychosis, severe depression and anxiety), epilepsy and comorbid substance misuseMental and Behavioural Disorders

Overview

Phase
N/A
Intervention
Not specified
Conditions
Mental, neurological and substance misuse disorders, which includes severe mental illness (psychosis, severe depression and anxiety), epilepsy and comorbid substance misuse
Sponsor
Queen Mary University of London
Enrollment
182
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

2019 Protocol article in https://pubmed.ncbi.nlm.nih.gov/31200671/ (added 11/08/2022) 2024 Results article in https://doi.org/10.4102/sajpsychiatry.v30i0.2138 (added 07/02/2024)

Registry
who.int
Start Date
November 20, 2018
End Date
June 25, 2020
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •1\. Primary diagnosis of severe mental illness (psychosis, bipolar disorder, psychotic/severe depression), epilepsy and/or co\-morbid substance misuse, assessed by the ICD\-10
  • •2\. Attending the outpatient clinic at Butabika, or surrounding clinics in Kampala for at least six months
  • •3\. Live within a 20km radius of Kampala city/or the clinic where recruitment will take place
  • •4\. Aged 18\-65 years old
  • •5\. Capacity to provide informed consent assessed by UBACC Score of \=14 after a maximum of 3 attempts
  • •6\. Scores 5 or below on the MANSA scale
  • •7\. Able to communicate in Luganda or English

Exclusion Criteria

  • •1\. Primary diagnosis of substance\-use disorder; organic psychosis and/or neurocognitive disorder
  • •2\. Currently an inpatient at the time of recruitment
  • •3\. Already participating in the DIALOG\+ study at another clinic or another study organised by this research group
  • •4\. Participating in another interventional study taking place at Butabika hospital

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
N/A
A research intervention in Uganda to test an intervention called Volunteer Support, designed to improve care for people living in the community with severe mental illnessPatients with severe mental illness (including psychosis)Mental and Behavioural Disorders
ISRCTN86689958Queen Mary University of London70
Completed
N/A
A research study in Colombia to test a Family Involvement intervention, designed to improve care for people living in the community with severe mental illnessPatients with severe mental illness (including psychosis)Mental and Behavioural Disorders
ISRCTN11440755Queen Mary University of London80
Completed
N/A
A research study in Colombia to test an intervention called DIALOG+, designed to improve care for people living in the community with severe mental illnessPatients with severe mental illness (including psychosis, bipolar disorder and severe depression)Mental and Behavioural Disorders
ISRCTN83333181Queen Mary University of London173
Completed
N/A
A research study in Pakistan to test an intervention called DIALOG+, designed to improve care for people living in the community with common mental disordersCommon mental disorders (mild-moderate depression and anxiety)Mental and Behavioural Disorders
ISRCTN14528579Queen Mary University of London44
Completed
N/A
A research study in Uganda to test a Family Involvement intervention, designed to improved care for people living in the community with severe mental illnessPatients with severe mental illness (including psychosis)Mental and Behavioural Disorders
ISRCTN78948497Queen Mary University of London118